239 related articles for article (PubMed ID: 33497363)
1. Particulate matter causes skin barrier dysfunction.
Kim BE; Kim J; Goleva E; Berdyshev E; Lee J; Vang KA; Lee UH; Han S; Leung S; Hall CF; Kim NR; Bronova I; Lee EJ; Yang HR; Leung DY; Ahn K
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497363
[TBL] [Abstract][Full Text] [Related]
2. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity.
Kezic S; O'Regan GM; Yau N; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Rowland M; McLean WH; Irvine AD
Allergy; 2011 Jul; 66(7):934-40. PubMed ID: 21261659
[TBL] [Abstract][Full Text] [Related]
3. A modified protocol for studying filaggrin degradation using a reconstructed human epidermis model under low and high humidity.
Chen Q; Wei N; Lu Y
Int J Cosmet Sci; 2024 Jun; 46(3):380-390. PubMed ID: 38124299
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid 1 plays a major role in low temperature-mediated skin barrier dysfunction.
Kim BE; Hui-Beckman J; Lyubchenko T; Hall CF; Fallahi S; Brull A; Goleva E; Leung DYM
J Allergy Clin Immunol; 2022 Aug; 150(2):362-372.e7. PubMed ID: 35189126
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis.
Jung M; Choi J; Lee SA; Kim H; Hwang J; Choi EH
J Dermatol Sci; 2014 Dec; 76(3):231-9. PubMed ID: 25315296
[TBL] [Abstract][Full Text] [Related]
6. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.
Kezic S; O'Regan GM; Lutter R; Jakasa I; Koster ES; Saunders S; Caspers P; Kemperman PM; Puppels GJ; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Fallon PG; McLean WH; Irvine AD
J Allergy Clin Immunol; 2012 Apr; 129(4):1031-9.e1. PubMed ID: 22322004
[TBL] [Abstract][Full Text] [Related]
7. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression.
Otsuka A; Doi H; Egawa G; Maekawa A; Fujita T; Nakamizo S; Nakashima C; Nakajima S; Watanabe T; Miyachi Y; Narumiya S; Kabashima K
J Allergy Clin Immunol; 2014 Jan; 133(1):139-46.e1-10. PubMed ID: 24055295
[TBL] [Abstract][Full Text] [Related]
8. Fermented blueberry and black rice containing Lactobacillus plantarum MG4221: a novel functional food for particulate matter (PM
Hong SM; Kang MC; Jin M; Lee TH; Lim BO; Kim SY
Food Funct; 2021 Apr; 12(8):3611-3623. PubMed ID: 33900308
[TBL] [Abstract][Full Text] [Related]
9. Particulate matter 2.5 induces the skin barrier dysfunction and cutaneous inflammation via AhR- and T helper 17 cell-related genes in human skin tissue as identified via transcriptome analysis.
Kim HB; Choi MG; Chung BY; Um JY; Kim JC; Park CW; Kim HO
Exp Dermatol; 2023 Apr; 32(4):547-554. PubMed ID: 36471583
[TBL] [Abstract][Full Text] [Related]
10. Air Pollution and Atopic Dermatitis (AD): The Impact of Particulate Matter (PM
Woo YR; Park SY; Choi K; Hong ES; Kim S; Kim HS
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846909
[TBL] [Abstract][Full Text] [Related]
11. Enhanced phenotype of calcipotriol-induced atopic dermatitis in filaggrin-deficient mice.
Xiao C; Sun Z; Gao J; Bai Y; Zhang C; Pang B; Qiao H; Fu M; Dang E; Wang G
FASEB J; 2021 May; 35(5):e21574. PubMed ID: 33855746
[TBL] [Abstract][Full Text] [Related]
12. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
Furue M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ambient Fine Particles PM
Li Q; Kang Z; Jiang S; Zhao J; Yan S; Xu F; Xu J
Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28085100
[TBL] [Abstract][Full Text] [Related]
15. Filaggrin deficiency leads to impaired lipid profile and altered acidification pathways in a 3D skin construct.
Vávrová K; Henkes D; Strüver K; Sochorová M; Školová B; Witting MY; Friess W; Schreml S; Meier RJ; Schäfer-Korting M; Fluhr JW; Küchler S
J Invest Dermatol; 2014 Mar; 134(3):746-753. PubMed ID: 24061166
[TBL] [Abstract][Full Text] [Related]
16. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis.
Naeem AS; Tommasi C; Cole C; Brown SJ; Zhu Y; Way B; Willis Owen SA; Moffatt M; Cookson WO; Harper JI; Di WL; Brown SJ; Reinheckel T; O'Shaughnessy RF
J Allergy Clin Immunol; 2017 Apr; 139(4):1228-1241. PubMed ID: 27913303
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of epidermal growth factor receptor, E-cadherin, and occludin in the skin of flaky tail mice is due to filaggrin and loricrin deficiencies.
Nakai K; Yoneda K; Hosokawa Y; Moriue T; Presland RB; Fallon PG; Kabashima K; Kosaka H; Kubota Y
Am J Pathol; 2012 Sep; 181(3):969-77. PubMed ID: 22796440
[TBL] [Abstract][Full Text] [Related]
18. Filaggrin-gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis.
Ota M; Sasaki T; Ebihara T; Yokosawa E; Murakami Y; Matsunaka H; Chinuki Y; Amagai M; Morita E
J Dermatol; 2021 Nov; 48(11):1688-1699. PubMed ID: 34322929
[TBL] [Abstract][Full Text] [Related]
19. Filaggrin and Skin Barrier Function.
Kezic S; Jakasa I
Curr Probl Dermatol; 2016; 49():1-7. PubMed ID: 26844893
[TBL] [Abstract][Full Text] [Related]
20. Low Threshold for Cutaneous Allergen Sensitization but No Spontaneous Dermatitis or Atopy in FLG-Deficient Mice.
Muhandes L; Chapsa M; Pippel M; Behrendt R; Ge Y; Dahl A; Yi B; Dalpke A; Winkler S; Hiller M; Boutin S; Beissert S; Jessberger R; Fallon PG; Roers A
J Invest Dermatol; 2021 Nov; 141(11):2611-2619.e2. PubMed ID: 33894197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
